Top Tweets for #bcelllymphomas

over 1 year ago

Multi-center effort of CD19 allo iPSC CAR-NK in B-cell lymphomas - @KrishPatelMD (@SarahCannonDocs/@SCRIOncology) https://t.co/KJrlpwlezL #Health #Medicine #Cancer #OncoDaily #Oncology #CARNK #BCellLymphomas #MedX

222

OncoDaily

@oncodaily

about 2 years ago

The architecture of MYC, BCL2, and BCL6 rearrangements across more than 800 mature B-cell lymphomas - @lk_hilton @BloodJournal @ASH_hematology @BCCancer #BCellLymphomas #Cancer #BCL2 #OncoDaily #Oncology #CancerCare https://t.co/flFqPu7wW7

192

MDPI Biology @MDPIBiologySubj

about 2 years ago

The Evolving Role of Bruton’s Tyrosine Kinase Inhibitors in B Cell Lymphomas 💡Full Text → https://t.co/cbGSsV8ppT by Shefali Mehra & colleagues @univmiami #BTK #Ibrutinib #BCellLymphomas #ScaffoldingProteins #PROTACs #CancerTherapy #TargetedTherapy

MDPIBiologySubj's tweet photo. The Evolving Role of Bruton’s Tyrosine Kinase Inhibitors in B Cell Lymphomas

💡Full Text → https://t.co/cbGSsV8ppT

by Shefali Mehra & colleagues @univmiami

#BTK
#Ibrutinib
#BCellLymphomas
#ScaffoldingProteins
#PROTACs
#CancerTherapy
#TargetedTherapy https://t.co/1GJ6Ul2nti

Journal of the @NCCN @JNCCN

almost 4 years ago

The November issue of @JNCCN is now available online! Featured: current @NCCN Guidelines on Pediatric Aggressive Mature #BCellLymphomas, insights into recent updates to #NCCNGuidelines for #GastrointestinalStromalTumors, and more! https://t.co/8t8aPaSww2 #lymsm #pedonc #GICSM

JNCCN's tweet photo. The November issue of @JNCCN is now available online! Featured: current @NCCN Guidelines on Pediatric Aggressive Mature #BCellLymphomas, insights into recent updates to #NCCNGuidelines for #GastrointestinalStromalTumors, and more! https://t.co/8t8aPaSww2 #lymsm #pedonc #GICSM https://t.co/mHUO9P9Rs0

Josep Tabernero @TaberneroJosep

almost 5 years ago

A huge step in controlling #BCellLymphomas 👇

Vall d’Hebron Institute of Oncology (VHIO)

@VHIO

almost 5 years ago

Presented at @ASH_hematology 2021 & published simultaneously in @NEJM, two studies co-authored by VHIO's @ab_pau & @pebarba assessed the efficacy & safety of novel treatment approaches against #B-CellLymphomas. ➕ https://t.co/fSgH679Wft

VHIO's tweet photo. Presented at @ASH_hematology 2021 & published simultaneously in @NEJM, two studies co-authored by VHIO's @ab_pau & @pebarba assessed the efficacy & safety of novel treatment approaches against #B-CellLymphomas.

➕ https://t.co/fSgH679Wft https://t.co/PRQUpbFdj8

BioAscend

@BioAscend

over 5 years ago

NOW AVAILABLE: Our full catalog of 2020 VCCs in #BCellLymphomas & #MultipleMyeloma. Visit https://t.co/JN0i5N564H to catch up on every webinar from TWO series covering updates in treatment – all on-demand, in one place & #CME-accredited. @unmc

BioAscend's tweet photo. NOW AVAILABLE: Our full catalog of 2020 VCCs in #BCellLymphomas & #MultipleMyeloma. Visit https://t.co/JN0i5N564H to catch up on every webinar from TWO series covering updates in treatment – all on-demand, in one place & #CME-accredited. @unmc https://t.co/yjhhBNPNIt

1stOncology @1stOncology

about 6 years ago

#NationalComprehensiveCancerNetwork® Adds #Monjuvi® (#Tafasitamab-cxix) to its Clinical Practice Guidelines in #Oncology for #BCellLymphomas $MOR https://t.co/LUQTzVLT9J

1stOncology @1stOncology

over 6 years ago

#CellectarBiosciences Announces #CLR131 Achieves Primary Efficacy Endpoints from Its Phase 2 #CLOVER1 Study in relapsed/refractory #BcellLymphomas and Completion of the Phase 1 relapsed/refractory #MultipleMyeloma Dose Escalation Study $CLRB https://t.co/sMfpJnoJ52

Journal of the @NCCN @JNCCN

over 7 years ago

Catch up on the latest updates to @NCCN Guidelines for #BCellLymphomas regarding treatment of transformed #FollicularLymphoma and relapsed/refractory FL and #DLBCL, and earn Free CME, CNE, and CEU credit: https://t.co/NI9BveWoyI #lymsm #oncololgy #CARTcell #PI3K

$JNCCN's tweet photo. Catch up on the latest updates to @NCCN Guidelines for #BCellLymphomas regarding treatment of transformed #FollicularLymphoma and relapsed/refractory FL and #DLBCL, and earn Free CME, CNE, and CEU credit: https://t.co/NI9BveWoyI #lymsm #oncololgy #CARTcell #PI3K https://t.co/aaTpqZkgck$

National Foundation for Cancer Research @NFCR

over 8 years ago

A new #clinicaltrial has been launched to evaluate a combination of five drugs for treating patients with #BCellLymphomas. Learn more here: https://t.co/viDpl9CZui #cancer #research #nfcr #hope #canceradvancement #therapy #combinationtherapy #lymphoma #nonhodgkinslymphoma

Top Tweets for #bcelllymphomas

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users